Clinical and immunological features of severe and moderate coronavirus disease 2019

10.1056/NEJMoa030747

10.1056/NEJMoa1211721

10.1056/NEJMoa2001017

Gralinski, 2020, Return of the coronavirus: 2019-nCoV, Viruses, 12, 10.3390/v12020135

10.1056/NEJMoa2001316

10.1016/S0140-6736(20)30154-9

10.1038/s41586-020-2012-7

10.1016/S0140-6736(20)30183-5

[No authors listed]. Interpretation of New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Version 6) (in Chinese). The National Health Commission of People’s Republic of China. http://www.nhc.gov.cn/yzygj/s7652m/202002/54e1ad5c2aac45c19eb541799bf637e9.shtml Accessed April 3, 2020.

10.1016/S0140-6736(20)30211-7

10.1016/j.chom.2016.01.007

10.4049/jimmunol.180.9.6411

Xu, 2004, Immunological responses against SARS-coronavirus infection in humans, Cell Mol Immunol, 1, 119

10.1615/CritRevImmunol.v18.i6.50

10.1038/nri1270

10.1016/S2213-2600(20)30076-X

Arabi, 2014, Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection, Ann Intern Med, 160, 389, 10.7326/M13-2486

10.1093/infdis/jiv381

10.1128/JVI.01281-09

Zhao, 2003, [Clinical pathology and pathogenesis of severe acute respiratory syndrome], Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, 17, 217

10.1073/pnas.1323279111

10.4049/jimmunol.181.8.5490

10.1093/infdis/jiv380

10.1016/j.ijid.2004.07.014

Yang, 2004, Hematological findings in SARS patients and possible mechanisms (review), Int J Mol Med, 14, 311

[No authors listed]. Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance. World Health Organization. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected Updated March 13, 2020. Accessed March 27, 2020